- Home
- GOVX vs ARTW Comparison
GOVX vs ARTW Comparison
Compare GOVX & ARTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GOVX | ARTW |
|---|---|---|
| Founded | 2001 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.2M | 11.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | GOVX | ARTW |
|---|---|---|
| Price | $0.33 | $2.24 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | ★ 547.9K | 27.8K |
| Earning Date | 11-13-2025 | 10-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.49 |
| Revenue | $3,353,560.00 | ★ $24,079,949.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $6.31 |
| Revenue Growth | ★ 8.52 | N/A |
| 52 Week Low | $0.37 | $1.43 |
| 52 Week High | $2.75 | $4.71 |
Technical Indicators
Market Signals| Indicator | GOVX | ARTW |
|---|---|---|
| Relative Strength Index (RSI) | 29.98 | 42.75 |
| Support Level | $0.37 | $2.30 |
| Resistance Level | $0.41 | $2.55 |
| Average True Range (ATR) | 0.03 | 0.14 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 1.01 | 8.82 |
Price Performance
Historical ComparisonAbout GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.
About ARTW Art's-Way Manufacturing Co. Inc.
Art's-Way Manufacturing Co Inc is a manufacturer of agricultural equipment. It has two reportable segments: Agricultural Products, and Modular Buildings. The Agricultural Products segment fabricates and sells farming products as well as related equipment and replacement parts for these products in the United States and world wide. Its Modular Buildings segment manufactures and installs modular buildings for animal containment and various laboratory uses. It derives revenues from the Agricultural Products segment.